Article
Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models
22 May 2023
Abstract excerpt
Cellular senescence is known to play a role in age-related skin function deterioration which potentially influences longevity. Here, a two-step phenotypic screening was performed to identify senotherapeutic peptides, leading to the identification of Peptide (Pep) 14. Pep 14 effectively decreased human dermal fibroblast senescence burden induced by Hutchinson-Gilford Progeria Syndrome (HGPS), chronological aging,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
